All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetes

Association of sulphonylurea treatment with all-cause and cardiovascular mortality: A systematic review and meta-analysis of observational studies

(2013) Thomas Forst et al.   Diabetes & Vascular Disease Research

The dynamics of life expectancy over the last six decades in elderly people with diabetes

(2012) S. Ioacara et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments

(2011) M. O. Gore et al.   EUROPEAN HEART JOURNAL

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

(2011) Tina Ken Schramm et al.   EUROPEAN HEART JOURNAL

Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study

(2010) Casper H Jørgensen et al.   Cardiovascular Diabetology

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE